DAPK启动子区异常甲基化模式在白血病诊断分型中的价值分析

阮红刚, 赵铮, 许腊梅, 等. DAPK启动子区异常甲基化模式在白血病诊断分型中的价值分析[J]. 临床血液学杂志, 2018, 31(8): 592-595. doi: 10.13201/j.issn.1004-2806-b.2018.08.006
引用本文: 阮红刚, 赵铮, 许腊梅, 等. DAPK启动子区异常甲基化模式在白血病诊断分型中的价值分析[J]. 临床血液学杂志, 2018, 31(8): 592-595. doi: 10.13201/j.issn.1004-2806-b.2018.08.006
RUAN Honggang, ZHAO Zheng, XU Lamei, et al. Analysis of the value of abnormal methylation pattern in the promoter region of DAPK in the diagnosis of leukemia[J]. J Clin Hematol, 2018, 31(8): 592-595. doi: 10.13201/j.issn.1004-2806-b.2018.08.006
Citation: RUAN Honggang, ZHAO Zheng, XU Lamei, et al. Analysis of the value of abnormal methylation pattern in the promoter region of DAPK in the diagnosis of leukemia[J]. J Clin Hematol, 2018, 31(8): 592-595. doi: 10.13201/j.issn.1004-2806-b.2018.08.006

DAPK启动子区异常甲基化模式在白血病诊断分型中的价值分析

  • 基金项目:

    2012年度省教育厅科研计划项目(No:D20122404)

详细信息
    通讯作者: 赵铮,E-mail:zhaozheng780@163.com
  • 中图分类号: R733.1

Analysis of the value of abnormal methylation pattern in the promoter region of DAPK in the diagnosis of leukemia

More Information
  • 目的:探讨抑癌基因DAPK启动子区异常甲基化模式作为潜在肿瘤标志物在白血病诊断分型中的价值。方法:采取亚硫酸氢盐测序法(BSP)对白血病细胞株和正常人外周血白细胞中抑癌基因DAPK启动子的异常甲基化模式进行分析;利用甲基化特异性PCR法(MSP)检验DAPK基因异常甲基化模式对于白血病诊断的效能。结果:Jurkat、U937、HL-60 3种细胞株的甲基化水平和正常细胞株比较差异有统计学意义(χ2=90.736,P<0.05;χ2=67.493,P<0.05;χ2=753.284,P<0.05),提示肿瘤细胞的甲基化水平远高于正常细胞,且HL-60细胞株中的DAPK基因甲基化水平显著高于Jurkat和U937细胞株。ANLL用MSP甲基化检测时特异度、准确度和灵敏度分别为100%(61/61)、82.9%(87/105)和58.7%(27/46),未发现白血病病理分型和MSP诊断之间的关系。结论:抑癌基因DAPK启动子区异常甲基化模式作为一种潜在肿瘤标志物,极大丰富了临床诊断白血病的方法,对于白血病的诊断分型有重要的临床意义。
  • 加载中
  • [1]

    Alizad Ghandforoush N,Chahardouli B,Rostami S,et al.Evaluation of minimal residual disease in acute myeloid leukemia with NPM1 marker[J].Int J Hematol Oncol Stem Cell Res,2016,10:147-152.

    [2]

    Mohammadi S,Ghaffari SH,Shaiegan M,et al.Curcumin veto the effects of osteopontin (OPN) specific inhibitor on leukemic stem cell colony forming potential via promotion of OPN overexpression[J].Int J Hematol Oncol Stem Cell Res,2016,10:120-129.

    [3]

    Mahmud H,Kornblau SM,Ter EA,et al.Epidermal growth factor receptor is expressed and active in a subset of acute myeloid leukemia[J].J Hematol Oncol,2016,9:64.

    [4]

    Shah MV,Hook CC,Call TG,et al.A population-based study of large granular lymphocyte leukemia[J].Blood Cancer J,2016,6:e455.

    [5]

    Hayashi A,Tanoshima R,Tsujimoto SI,et al.Crizotinib treatment for refractory pediatric acute myeloid leukemia with RAN-binding protein 2-anaplastic lymphoma kinase fusion gene[J].Blood Cancer J,2016,6:e456.

    [6]

    Hidalgo Lopez JE,Yabe M,Carballo-Zarate AA,et al.Donor-derived T-cell large granular lymphocytic leukemia in a patient with peripheral T-cell lymphoma[J].J Natl Compr Canc Netw,2016,14:939-944.

    [7]

    苏庸春,徐红珍,于洁,等.5-氮杂胞苷对HL60细胞P16、DAPK及MGMT基因甲基化状态影响[J].重庆医科大学学报,2012,37(10):864-867.

    [8]

    赵卫华,孟凡义,赖永榕,等.DAPK过表达对HL-60细胞生物学功能及caspase-3表达的影响[J].南方医科大学学报,2016,36(5):729-732.

    [9]

    Kalaycio M.Your patient has chronic leukemia:Now what[J].Cleve Clin J Med,2016,83:575-581.

  • 加载中
计量
  • 文章访问数:  191
  • PDF下载数:  433
  • 施引文献:  0
出版历程
收稿日期:  2017-12-26

目录